Frontiers in Chemistry (Nov 2021)

A Small Ligand That Selectively Binds to the G-quadruplex at the Human Vascular Endothelial Growth Factor Internal Ribosomal Entry Site and Represses the Translation

  • Xiao-Xia Hu,
  • Xiao-Xia Hu,
  • Sheng-Quan Wang,
  • Shi-Quan Gan,
  • Lei Liu,
  • Ming-Qing Zhong,
  • Meng-Hao Jia,
  • Fei Jiang,
  • Yan Xu,
  • Chao-Da Xiao,
  • Chao-Da Xiao,
  • Xiang-Chun Shen,
  • Xiang-Chun Shen

DOI
https://doi.org/10.3389/fchem.2021.781198
Journal volume & issue
Vol. 9

Abstract

Read online

G-quadruplexes are believed to have important biological functions, so many small molecules have been screened or developed for targeting G-quadruplexes. However, it is still a major challenge to find molecules that recognize specific G-quadruplexes. Here, by using a combination of surface plasmon resonance, electrospray ionization mass spectrometry, circular dichroism, Western blot, luciferase assay, and reverse transcriptase stop assay, we observed a small molecule, namely, oxymatrine (OMT) that could selectively bind to the RNA G-quadruplex in 5′-untranslated regions (UTRs) of human vascular endothelial growth factor (hVEGF), but could not bind to other G-quadruplexes. OMT could selectively repress the translation of VEGF in cervical cancer cells. Furthermore, it could recognize VEGF RNA G-quadruplexes in special conformations. The results indicate that OMT may serve as a potentially special tool for studying the VEGF RNA G-quadruplex in cells and as a valuable scaffold for the design of ligands that recognize different G-quadruplexes.

Keywords